Manufacturer | Source: CBN

Published On: 27-02-2026

Enforcement Date: 27 February, 2026

Issuance of CBN Registration Certificate (CRC) Physical Form under Rule 65 of the NDPS Rules, 1985

The Central Bureau of Narcotics (CBN), Government of India, has begun issuing CBN Registration Certificates (CRC) in physical form under Rule 65 of the NDPS Rules, 1985. All manufacturers of psychotropic substances must register with the Narcotics Commissioner and are allotted a permanent registration number. To address difficulties caused by the absence of a formal certificate, CRCs with enhanced security features will now be issued. Applications can be submitted via email or other means, and companies must ensure accuracy of details and documents to avoid delays. This notice informs all registered companies and stakeholders of the new process.

The Central Bureau of Narcotics (CBN), Government of India, has announced the issuance of the CBN Registration Certificate (CRC) in physical form under Rule 65 of the NDPS Rules, 1985. As per the rule, all manufacturers of psychotropic substances must register with the Narcotics Commissioner, CBN, and are assigned a unique permanent registration number. To resolve challenges faced by companies due to the absence of a formal certificate, the CBN will now provide CRCs with enhanced security features. Applications for the certificate can be submitted in the prescribed format via email to supdt-online@cbn.nic.in or through other means. Each application will be carefully scrutinized before certificates are issued. Companies are advised to ensure accuracy and completeness of all details and documents to avoid delays. This notice serves as official information for all registered companies and relevant stakeholders regarding the new certificate issuance process.

Applicable For: Manufacturer

Reference Number: F.No. XVI-5-ON/5/2025-XVI- Notification Link

In exercise of the powers conferred by sub-clause (b) of clause (xi) of section 2 of the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby declares the following substances, salts and preparations thereof to be manufactured drugs, namely:

Importer | CBN 12 March, 2026

The Government of India has issued a notification under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, declaring several synthetic substances and related compounds as manufactured drugs and psychotropic substances. These include protonitazene derivatives, etonitazene derivatives, Hexahydrocannabinol (HHC), and Carisoprodol. The notification also specifies their small and commercial quantity limits for regulatory and enforcement purposes.

ENQUIRE NOW

Notification of Manufacturers under Rule 54 of NDPS Rules, 1985 (Effective for the period upto 31st December, 2027)

Importer | CBN 02 January, 2026

The Central Government has permitted 15 specified pharmaceutical manufacturers to import morphine, codeine, thebaine, and their salts for exclusive use in manufacturing drugs or formulations meant for export. Imports must comply with the NDPS Rules, 1985, with strict timelines for export, surrender of unutilised quantities, and oversight by the Narcotics Commissioner. The notification remains valid until 31 December 2027.

ENQUIRE NOW

Notification regarding amendment in Form No. 4A (Import Certificate for Import of Narcotics Drugs under Rule 54) and Form No. 5 (Export Authorization for Export of Narcotics Drugs and Psychotropic Substances) of NDPS Rules, 1985.

Importer | CBN 24 December, 2025

The Ministry of Finance notified the NDPS (Amendment) Rules, 2025 on 10 December 2025, revising import and export procedures for narcotic drugs under Sections 4, 9, and 76 of the NDPS Act, 1985. Key reforms include updated Form 4A for import approval and Form 5 for export documentation. The changes strengthen compliance, enhance traceability, and align India’s framework with international standards. Importers must meet stricter timelines, reporting, and accounting requirements, while exporters face expanded documentation obligations to prevent diversion and misuse.

ENQUIRE NOW